NCT04561141

Brief Summary

Aim(s) of the Research :

  1. 1.Identify post covid symptoms
  2. 2.prevalance of post covid syndrome among survivours

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 23, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

September 25, 2020

Status Verified

September 1, 2020

Enrollment Period

1 year

First QC Date

September 22, 2020

Last Update Submit

September 23, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identify post covid symptoms

    by interview questionnaire

    after 4 weeks of diagnosis

Secondary Outcomes (1)

  • prevalance of post covid syndrome among survivours

    after 4 weeks of diagnosis

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

will be carried out in Assuit university hospital among health team workers(doctors, nurses, employes), in Emergency room(ER) , clinics , ICU and wards for patients who had covid 19

You may qualify if:

  • patients diagnosed as covid 19 with chest ct and/or nasopharyngeal swab for covid 19
  • age 18 years old and above
  • post covid syndrome after 6 weeks

You may not qualify if:

  • below age of 18 2 -not confirmed cases 3. symptoms less than 6 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Lamia Hassan Shaban, professor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

September 22, 2020

First Posted

September 23, 2020

Study Start

December 1, 2020

Primary Completion

December 1, 2021

Study Completion

January 1, 2022

Last Updated

September 25, 2020

Record last verified: 2020-09